# Percello

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/percello

- Industry: Semiconductors
- Headquarters: Ra'anana, Israel
- Website: www.percello.com
- Total disclosed funding: $12M
- Latest round: Series B (Sep 9, 2008)
- Investors on record: 3

## About

Percello Ltd. is a specialized medical company focused on penile lengthening procedures, offering both surgical and non-surgical options tailored to individual client needs, enhancing confidence and quality of life for men experiencing dissatisfaction with genital size.Founded in 2007 and headquartered in Ra'anana, Israel, Percello Ltd. specializes in medical procedures aimed at penile lengthening. The company has not undergone any significant pivots or changes in its operations. In October 2010, Percello was acquired by Broadcom Corp for USD 86 mn. The company has secured a total amount raised of USD 86 mn, primarily through this Trade Sale deal. The firm has participated in 3 deals since its inception.Percello Ltd. specializes in penile lengthening procedures, offering both surgical and non-surgical options. These services cater to men aged 18 and older who experience anxiety regarding penile size. The offerings include invasive techniques, such as surgical procedures, and less invasive methods that utilize specialized materials for lengthening without incisions. The company targets diverse geographic markets, primarily urban centers in Japan, with potential expansion plans into other regions.Percello Ltd. generates revenue through a fee-for-service model, with individual lengthening procedures priced between 300,000 and 400,000 yen. The company engages directly with consumers, providing consultations to inform clients about procedure options and associated costs. They also implement promotional campaigns that offer discounts, enhancing accessibility while ensuring a reliable revenue stream.Percello Ltd. plans to leverage its recent acquisition funding to enhance its service offerings and expand into new geographic markets, specifically targeting additional urban centers in Asia by the end of 2011. The company aims to develop new products related to its existing service lines, although specific details regarding upcoming launches have not been disclosed. The strategic focus will enable Percello to diversify its client base and solidify its presence in the growing demand for penile enhancement procedures.

## Funding rounds

- Series B, Sep 9, 2008, $12M — Vertex Ventures Israel, DTCP, Granite Ventures

## Investors

- Vertex Ventures Israel (https://capitalatlas.ai/funds/vertex-ventures-israel) — Series B
- DTCP — Series B
- Granite Ventures (https://capitalatlas.ai/funds/granite-ventures) — Series B